Training program for researchers focused on sickle cell disease and related conditions in Africa
Sickle Pan Africa Research Consortium TRAINing (SPARC- TRAIN) Program
This study is creating a special training program for future leaders in West Africa to help them learn about sickle cell disease and related conditions, so they can improve health care and make a positive difference in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Abuja NIH-funded |
| Lab location | 1 site (Abuja, Nigeria) |
| Project ID | NIH-11062463 on NIH RePORTER |
What this research studies
This research aims to develop a comprehensive training program for scholars in Nigeria, Ghana, and other West African countries, focusing on sickle cell disease (SCD) and related hemoglobinopathies like beta thalassemia. The program will recruit talented individuals who aspire to become leaders in this field and provide them with mentorship, education, and hands-on experience in clinical research. Scholars will engage in interdisciplinary training that addresses the gaps in translating evidence-based interventions into public health practices, ultimately promoting health equity. The program will also evaluate the outcomes of these interventions on various health conditions associated with hemoglobinopathies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals living with sickle cell disease or beta thalassemia, particularly in Nigeria and Ghana.
Not a fit: Patients outside of West Africa or those without hemoglobinopathies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and better management of sickle cell disease and related conditions in affected populations.
How similar studies have performed: Previous research has shown success in training programs aimed at improving health outcomes for hemoglobinopathies, indicating that this approach has potential.
Where this research is happening
Abuja, Nigeria
- University of Abuja — Abuja, Nigeria (Active)
Researchers
- Principal investigator: Nnodu, Obiageli Eunice — University of Abuja
- Study coordinator: Nnodu, Obiageli Eunice
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.